Clinical Trial 46842

Tulsa, OK 74133


A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety, Efficacy and Pharmacodynamics of drug Administered Subcutaneously in Adult Patients with Persistent Eosinophilic Asthma. 


The patient has a diagnosis of asthma for at least 6 months as defined by the National Institutes of Health (NIH) and has been stable without exacerbation or change in medications for at least 3 months. The patient has an absolute blood eosinophil count ≥300 cells/μL demonstrated during the screening period. The patient is able to provide diary entries daily using a handheld device at home and also come into clinic on visit days to provide blood and perform spirometry. 

Qualified Participants May Receive:

Each qualified participant will receive $60 for their time for each visit to the clinic (Total of 10 clinic visits completed in about 8 months time).

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.